|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yildiz-Aktas IZ, Dabbs DJ and Bhargava R:
The effect of cold ischemic time on the immunohistochemical
evaluation of estrogen receptor, progesterone receptor, and HER2
expression in invasive breast carcinoma. Mod Pathol. 25:1098–1105.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barnes DM, Millis RR, Beex LV, Thorpe SM
and Leake RE: Increased use of immunohistochemistry for oestrogen
receptor measurement in mammary carcinoma: The need for quality
assurance. Eur J Cancer. 34:1677–1682. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harris L, Fritsche H, Mennel R, Norton L,
Ravdin P, Taube S, Somerfield MR, Hayes DF and Bast RC Jr; American
Society of Clinical Oncology, : American Society of Clinical
Oncology 2007 update of recommendations for the use of tumor
markers in breast cancer. J Clin Oncol. 25:5287–5312. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dowsett M, Allred C, Knox J, Quinn E,
Salter J, Wale C, Cuzick J, Houghton J, Williams N, Mallon E, et
al: Relationship between quantitative estrogen and progesterone
receptor expression and human epidermal growth factor receptor 2
(HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or
in Combination trial. J Clin Oncol. 26:1059–1065. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rhodes A, Jasani B, Balaton AJ, Barnes DM
and Miller KD: Frequency of oestrogen and progesterone receptor
positivity by immunohistochemical analysis in 7016 breast
carcinomas: Correlation with patient age, assay sensitivity,
threshold value, and mammographic screening. J Clin Pathol.
53:688–696. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wolff AC, Hammond ME, Schwartz JN, Hagerty
KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer
A, et al American Society of Clinical Oncology; College of American
Pathologists, : American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for human epidermal
growth factor receptor 2 testing in breast cancer. J Clin Oncol.
25:118–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khoury T, Sait S, Hwang H, Chandrasekhar
R, Wilding G, Tan D and Kulkarni S: Delay to formalin fixation
effect on breast biomarkers. Mod Pathol. 22:1457–1467. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moatamed NA, Nanjangud G, Pucci R, Lowe A,
Shintaku IP, Shapourifar-Tehrani S, Rao N, Lu DY and Apple SK:
Effect of ischemic time, fixation time, and fixative type on
HER2/neu immunohistochemical and fluorescence in situ hybridization
results in breast cancer. Am J Clin Pathol. 136:754–761. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Portier BP, Wang Z, Downs-Kelly E, Rowe
JJ, Patil D, Lanigan C, Budd GT, Hicks DG, Rimm DL and Tubbs RR:
Delay to formalin fixation ‘cold ischemia time’: Effect on ERBB2
detection by in-situ hybridization and immunohistochemistry. Mod
Pathol. 26:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reddy JC, Reimann JD, Anderson SM and
Klein PM: Concordance between central and local laboratory HER2
testing from a community-based clinical study. Clin Breast Cancer.
7:153–157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nuovo AJ, Garofalo M, Mikhail A, Nicol AF,
Vianna-Andrade C and Nuovo GJ: The effect of aging of
formalin-fixed paraffin-embedded tissues on the in situ
hybridization and immunohistochemistry signals in cervical lesions.
Diagn Mol Pathol. 22:164–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goldstein NS, Ferkowicz M, Odish E, Mani A
and Hastah F: Minimum formalin fixation time for consistent
estrogen receptor immunohistochemical staining of invasive breast
carcinoma. Am J Clin Pathol. 120:86–92. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human Epidermal Growth Factor Receptor 2 Testing in
Breast Cancer: American Society of Clinical Oncology/College of
American Pathologists Clinical Practice Guideline Focused Update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moelans CB, Oostenrijk D, Moons MJ and van
Diest PJ: Formaldehyde substitute fixatives: Effects on nucleic
acid preservation. J Clin Pathol. 64:960–967. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dapson RW: Glyoxal fixation: How it works
and why it only occasionally needs antigen retrieval. Biotech
Histochem. 82:161–166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dapson RW: Macromolecular changes caused
by formalin fixation and antigen retrieval. Biotech Histochem.
82:133–140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Perlmutter MA, Best CJM, Gillespie JW,
Gathright Y, González S, Velasco A, Linehan WM, Emmert-Buck MR and
Chuaqui RF: Comparison of snap freezing versus ethanol fixation for
gene expression profiling of tissue specimens. J Mol Diagn.
6:371–377. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scicchitano MS, Dalmas DA, Bertiaux MA,
Anderson SM, Turner LR, Thomas RA, Mirable R and Boyce RW:
Preliminary comparison of quantity, quality, and microarray
performance of RNA extracted from formalin-fixed,
paraffin-embedded, and unfixed frozen tissue samples. J Histochem
Cytochem. 54:1229–1237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nirmalan NJ, Harnden P, Selby PJ and Banks
RE: Development and validation of a novel protein extraction
methodology for quantitation of protein expression in
formalin-fixed paraffin-embedded tissues using western blotting. J
Pathol. 217:497–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hewitt SM, Lewis FA, Cao Y, Conrad RC,
Cronin M, Danenberg KD, Goralski TJ, Langmore JP, Raja RG, Williams
PM, et al: Tissue handling and specimen preparation in surgical
pathology: Issues concerning the recovery of nucleic acids from
formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med.
132:1929–1935. 2008.PubMed/NCBI
|
|
22
|
Chung JY, Braunschweig T, Williams R,
Guerrero N, Hoffmann KM, Kwon M, Song YK, Libutti SK and Hewitt SM:
Factors in tissue handling and processing that impact RNA obtained
from formalin-fixed, paraffin-embedded tissue. J Histochem
Cytochem. 56:1033–1042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cronin M, Pho M, Dutta D, Stephans JC,
Shak S, Kiefer MC, Esteban JM and Baker JB: Measurement of gene
expression in archival paraffin-embedded tissues: Development and
performance of a 92-gene reverse transcriptase-polymerase chain
reaction assay. Am J Pathol. 164:35–42. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fergenbaum JH, Garcia-Closas M, Hewitt SM,
Lissowska J, Sakoda LC and Sherman ME: Loss of antigenicity in
stored sections of breast cancer tissue microarrays. Cancer
Epidemiol Biomarkers Prev. 13:667–672. 2004.PubMed/NCBI
|
|
25
|
Wester K, Wahlund E, Sundström C, Ranefall
P, Bengtsson E, Russell PJ, Ow KT, Malmström PU and Busch C:
Paraffin section storage and immunohistochemistry. Effects of time,
temperature, fixation, and retrieval protocol with emphasis on p53
protein and MIB1 antigen. Appl Immunohistochem Mol Morphol.
8:61–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie R, Chung JY, Ylaya K, Williams RL,
Guerrero N, Nakatsuka N, Badie C and Hewitt SM: Factors influencing
the degradation of archival formalin-fixed paraffin-embedded tissue
sections. J Histochem Cytochem. 59:356–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van den Broek LJ and van de Vijver MJ:
Assessment of problems in diagnostic and research
immunohistochemistry associated with epitope instability in stored
paraffin sections. Appl Immunohistochem Mol Morphol. 8:316–321.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jacobs TW, Prioleau JE, Stillman IE and
Schnitt SJ: Loss of tumor marker-immunostaining intensity on stored
paraffin slides of breast cancer. J Natl Cancer Inst. 88:1054–1059.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
DiVito KA, Charette LA, Rimm DL and Camp
RL: Long-term preservation of antigenicity on tissue microarrays.
Lab Invest. 84:1071–1078. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mirlacher M, Kasper M, Storz M, Knecht Y,
Dürmüller U, Simon R, Mihatsch MJ and Sauter G: Influence of slide
aging on results of translational research studies using
immunohistochemistry. Mod Pathol. 17:1414–1420. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stoler MH: Toward objective cervical
cancer screening: Maybe the eyes do have it. Am J Clin Pathol.
134:5–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Copete M, Garratt J, Gilks B, Pilavdzic D,
Berendt R, Bigras G, Mitchell S, Lining LA, Cheung C and Torlakovic
EE: Inappropriate calibration and optimisation of pan-keratin
(pan-CK) and low molecular weight keratin (LMWCK)
immunohistochemistry tests: Canadian Immunohistochemistry Quality
Control (CIQC) experience. J Clin Pathol. 64:220–225. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Denton KJ, Bergeron C, Klement P, Trunk
MJ, Keller T and Ridder R; European CINtec Cytology Study Group, :
The sensitivity and specificity of p16(INK4a) cytology vs HPV
testing for detecting high-grade cervical disease in the triage of
ASC-US and LSIL pap cytology results. Am J Clin Pathol. 134:12–21.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer (Unabridged Version). Arch Pathol Lab Med.
134:e48–e72. 2010.PubMed/NCBI
|
